Completed PHASE3 INTERVENTIONAL 4-arm NCT00063323

Maintenance Treatment for Abstinent Smokers

Maintenance Treatment for Prevention of Smoking Relapse

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Bupropion

Updated 6 times since 2017 Last updated: Jan 11, 2017 Started: Aug 31, 2000 Primary completion: Jul 31, 2006 Completion: Jul 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00063323, this PHASE3 trial focuses on Tobacco Use Disorder and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 6 times since 2000, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Feb 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Aug 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
Research Foundation for Mental Hygiene, Inc.

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States